1. Home
  2. ANNX vs BBW Comparison

ANNX vs BBW Comparison

Compare ANNX & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANNX
  • BBW
  • Stock Information
  • Founded
  • ANNX 2011
  • BBW 1997
  • Country
  • ANNX United States
  • BBW United States
  • Employees
  • ANNX N/A
  • BBW N/A
  • Industry
  • ANNX Biotechnology: Pharmaceutical Preparations
  • BBW Recreational Games/Products/Toys
  • Sector
  • ANNX Health Care
  • BBW Consumer Discretionary
  • Exchange
  • ANNX Nasdaq
  • BBW Nasdaq
  • Market Cap
  • ANNX 622.3M
  • BBW 517.9M
  • IPO Year
  • ANNX 2020
  • BBW 2004
  • Fundamental
  • Price
  • ANNX $7.36
  • BBW $37.34
  • Analyst Decision
  • ANNX Strong Buy
  • BBW Strong Buy
  • Analyst Count
  • ANNX 7
  • BBW 3
  • Target Price
  • ANNX $15.80
  • BBW $39.67
  • AVG Volume (30 Days)
  • ANNX 1.3M
  • BBW 196.3K
  • Earning Date
  • ANNX 11-19-2024
  • BBW 11-29-2024
  • Dividend Yield
  • ANNX N/A
  • BBW 2.14%
  • EPS Growth
  • ANNX N/A
  • BBW 2.42
  • EPS
  • ANNX N/A
  • BBW 3.56
  • Revenue
  • ANNX N/A
  • BBW $483,367,000.00
  • Revenue This Year
  • ANNX N/A
  • BBW $2.56
  • Revenue Next Year
  • ANNX N/A
  • BBW $2.52
  • P/E Ratio
  • ANNX N/A
  • BBW $10.51
  • Revenue Growth
  • ANNX N/A
  • BBW 0.94
  • 52 Week Low
  • ANNX $2.05
  • BBW $21.24
  • 52 Week High
  • ANNX $8.40
  • BBW $40.13
  • Technical
  • Relative Strength Index (RSI)
  • ANNX 55.04
  • BBW 61.57
  • Support Level
  • ANNX $6.85
  • BBW $37.45
  • Resistance Level
  • ANNX $7.63
  • BBW $40.13
  • Average True Range (ATR)
  • ANNX 0.29
  • BBW 1.09
  • MACD
  • ANNX -0.06
  • BBW -0.16
  • Stochastic Oscillator
  • ANNX 57.30
  • BBW 52.96

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

Share on Social Networks: